NTRK fusions involve the fusion of NTRK1, NTRK2, or NTRK3 with various partner genes, leading to constitutive activation of the TRK signaling pathway, which promotes tumor growth, survival, and metastasis. This evidence concerns the gene NTRK1 and neoplasm.